Vir Biotechnology, Inc.
NASDAQ:VIR
7.8 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3.075 | 56.376 | 16.787 | -4.098 | -12.722 | 46.712 | 21.789 | 371.432 | -42.687 | 1,229.938 | 809.756 | 102.713 | 173.986 | 0.605 | 0.301 | 0.188 | 66.269 | 0.487 | 0.371 | 0.237 | 0.086 | 0.017 | 0.006 | 0.114 | 2.329 | 2.329 |
| Cost of Revenue
| 4.312 | 4.576 | 5.277 | 0.038 | 0.022 | 1.907 | 5.996 | 22.253 | 27.921 | 90.149 | 56.877 | 7.836 | 1.144 | 134.87 | 0.301 | 70.684 | 79.653 | 57.814 | 53.75 | 39.863 | 29.805 | 25.872 | 23.823 | 29.837 | 23.195 | 23.195 |
| Gross Profit
| -1.237 | 51.8 | 11.51 | -4.136 | -12.744 | 44.805 | 15.793 | 349.179 | -70.608 | 1,139.789 | 752.879 | 94.877 | 172.842 | -134.265 | 0 | -70.496 | -13.384 | -57.327 | -53.379 | -39.626 | -29.719 | -25.855 | -23.817 | -29.723 | -20.866 | -20.866 |
| Gross Profit Ratio
| -0.402 | 0.919 | 0.686 | 1.009 | 1.002 | 0.959 | 0.725 | 0.94 | 1.654 | 0.927 | 0.93 | 0.924 | 0.993 | -221.926 | 0 | -374.979 | -0.202 | -117.715 | -143.879 | -167.198 | -345.57 | -1,520.882 | -3,969.5 | -260.728 | -8.961 | -8.961 |
| Reseach & Development Expenses
| 97.863 | 68.008 | 89.536 | 148.253 | 171.86 | 157.643 | 155.173 | 114.166 | 115.082 | 90.227 | 128.341 | 98.669 | 86.126 | 134.87 | 87.095 | 70.684 | 79.653 | 64.979 | 52.932 | 39.863 | 29.805 | 25.872 | 21.973 | 29.837 | 24.21 | 24.21 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.739 | 0 | 0 | 25.739 | 23.043 | 18.859 | 16.386 | 12.649 | 11.807 | 9.22 | 8.011 | 8.559 | 7.949 | 7.394 | 6.894 | 6.894 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30.038 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 0 |
| SG&A
| 30.265 | 36.273 | 39.09 | 41.08 | 47.101 | 46.778 | 38.743 | 43.174 | 41.59 | 38.255 | 55.777 | 50.496 | 28.781 | 25.739 | 23.043 | 18.859 | 16.386 | 12.649 | 11.807 | 9.22 | 8.011 | 8.559 | 7.949 | 7.394 | 6.894 | 6.894 |
| Other Expenses
| -0.535 | -0.287 | -1.485 | 0.882 | -0.367 | -16.245 | -27.621 | -3.125 | 0.691 | -2.521 | -0.007 | 0.064 | 0.752 | -10.246 | 2.437 | 2.616 | -2.895 | -7.069 | -1.81 | -2.659 | -0.447 | -0.145 | -0.198 | 0.178 | 0 | 0 |
| Operating Expenses
| 128.128 | 104.281 | 128.626 | 182.596 | 202.442 | 188.176 | 166.295 | 154.215 | 154.614 | 125.961 | 181.127 | 148.262 | 111.825 | 159.238 | 108.705 | 87.803 | 95.32 | 72.397 | 64.13 | 47.917 | 35.855 | 30.787 | 26.802 | 34.46 | 8.005 | 8.005 |
| Operating Income
| -129.365 | -52.481 | -117.116 | -186.732 | -215.186 | -143.371 | -150.502 | 194.964 | -225.222 | 1,013.828 | 571.752 | -53.385 | 61.017 | -158.633 | -108.404 | -87.615 | -29.051 | -71.91 | -63.759 | -47.68 | -35.769 | -30.77 | -26.796 | -34.346 | -27.76 | -27.76 |
| Operating Income Ratio
| -42.07 | -0.931 | -6.977 | 45.567 | 16.914 | -3.069 | -6.907 | 0.525 | 5.276 | 0.824 | 0.706 | -0.52 | 0.351 | -262.203 | -360.146 | -466.037 | -0.438 | -147.659 | -171.857 | -201.181 | -415.919 | -1,810 | -4,466 | -301.281 | -11.922 | -11.922 |
| Total Other Income Expenses Net
| -10.525 | -12.519 | -3.641 | -1.825 | -5.453 | 0.183 | -1.136 | 22.768 | -10.699 | -91.921 | -26.03 | 164.136 | 0.752 | -10.246 | 2.437 | 2.616 | -2.895 | -7.069 | -1.81 | -2.659 | -0.447 | -0.145 | -0.198 | 0.178 | -0.508 | -0.508 |
| Income Before Tax
| -139.89 | -65 | -120.757 | -166.626 | -197.623 | -143.188 | -151.638 | 217.732 | -233.721 | 921.907 | 545.889 | 110.762 | 61.866 | -168.715 | -105.679 | -84.587 | -31.121 | -77.224 | -63.622 | -48.327 | -33.909 | -28.67 | -26.373 | -33.456 | -28.268 | -28.268 |
| Income Before Tax Ratio
| -45.493 | -1.153 | -7.193 | 40.66 | 15.534 | -3.065 | -6.959 | 0.586 | 5.475 | 0.75 | 0.674 | 1.078 | 0.356 | -278.868 | -351.093 | -449.931 | -0.47 | -158.571 | -171.488 | -203.911 | -394.291 | -1,686.471 | -4,395.5 | -293.474 | -12.14 | -12.14 |
| Income Tax Expense
| -1.512 | 0.276 | -4.784 | -3.213 | -2.848 | -2.232 | -50.035 | 42.42 | -157.228 | 403.286 | 20.635 | 0.334 | 0.053 | 0.196 | -0.03 | 0.022 | 0.046 | 0.016 | 0.149 | -0.013 | 0.019 | -2.245 | 0.02 | -0.712 | 0.25 | 0.25 |
| Net Income
| -138.378 | -65.276 | -115.973 | -163.413 | -194.775 | -140.956 | -101.603 | 175.312 | -76.493 | 518.621 | 525.254 | 110.428 | 61.813 | -168.911 | -105.649 | -84.609 | -31.167 | -77.24 | -63.771 | -48.314 | -33.928 | -28.67 | -26.393 | -33.456 | -28.018 | -28.018 |
| Net Income Ratio
| -45.001 | -1.158 | -6.909 | 39.876 | 15.31 | -3.018 | -4.663 | 0.472 | 1.792 | 0.422 | 0.649 | 1.075 | 0.355 | -279.192 | -350.993 | -450.048 | -0.47 | -158.604 | -171.889 | -203.857 | -394.512 | -1,686.471 | -4,398.833 | -293.474 | -12.032 | -12.032 |
| EPS
| -1.02 | -0.48 | -0.86 | -1.22 | -1.45 | -1.06 | -0.76 | 1.32 | -0.58 | 3.93 | 4.01 | 0.85 | 0.48 | -1.32 | -0.83 | -0.67 | -0.27 | -0.71 | -0.69 | -0.44 | -0.31 | -0.3 | -0.27 | -0.35 | -4.02 | -4.02 |
| EPS Diluted
| -1.02 | -0.48 | -0.86 | -1.22 | -1.45 | -1.06 | -0.76 | 1.3 | -0.58 | 3.85 | 3.92 | 0.82 | 0.46 | -1.32 | -0.83 | -0.67 | -0.27 | -0.71 | -0.69 | -0.44 | -0.31 | -0.3 | -0.27 | -0.35 | -4.02 | -4.02 |
| EBITDA
| -125.105 | -47.964 | -112.637 | -184.025 | -210.1 | -130.268 | -159.381 | 208.554 | -212.236 | 1,110.419 | 597.775 | -215.971 | 62.419 | -157.231 | -108.404 | -87.615 | -27.684 | -70.604 | -63.759 | -46.472 | -34.636 | -29.758 | -25.898 | -33.604 | -27.452 | -27.452 |
| EBITDA Ratio
| -40.685 | -0.851 | -6.71 | 44.906 | 16.515 | -2.789 | -7.315 | 0.561 | 4.972 | 0.903 | 0.738 | -2.103 | 0.359 | -259.886 | -360.146 | -466.037 | -0.418 | -144.977 | -171.857 | -196.084 | -402.744 | -1,750.471 | -4,316.333 | -294.772 | -11.79 | -11.79 |